These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23171340)

  • 1. Strengths and weaknesses of pharmacogenetic studies of antipsychotic drugs: the potential value of the PEPs study.
    Mas S; Llerena A; Saíz J; Bernardo M; Lafuente A
    Pharmacogenomics; 2012 Nov; 13(15):1773-82. PubMed ID: 23171340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics of psychotropic drug response.
    Malhotra AK; Murphy GM; Kennedy JL
    Am J Psychiatry; 2004 May; 161(5):780-96. PubMed ID: 15121641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing clinical and functional outcomes in a gene-environment interaction study in first episode of psychosis (PEPs).
    Bernardo M; Bioque M; Parellada M; Saiz Ruiz J; Cuesta MJ; Llerena A; Sanjuán J; Castro-Fornieles J; Arango C; Cabrera B;
    Rev Psiquiatr Salud Ment; 2013; 6(1):4-16. PubMed ID: 23206389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics and outcome with antipsychotic drugs.
    Pouget JG; Shams TA; Tiwari AK; Müller DJ
    Dialogues Clin Neurosci; 2014 Dec; 16(4):555-66. PubMed ID: 25733959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of CYP2D6 and TaqI A polymorphisms in malignant neuroleptic syndrome: two case reports with three episodes.
    Zivković M; Mihaljević-Peles A; Sagud M; Silić A; Mihanović M
    Psychiatr Danub; 2010 Mar; 22(1):112-6. PubMed ID: 20305604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancing psychiatric pharmacogenomics using drug development paradigms.
    Smith RM
    Pharmacogenomics; 2017 Oct; 18(15):1459-1467. PubMed ID: 28975860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacogenetics in psychiatry: how far are we from clinical application?].
    Daray FM; Maffia PC; Rothlin RP; Errasti AE
    Vertex; 2012; 23(104):299-309. PubMed ID: 23170302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetic testing in psychiatry: a review of features and clinical realities.
    de Leon J; Arranz MJ; Ruaño G
    Clin Lab Med; 2008 Dec; 28(4):599-617. PubMed ID: 19059065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacogenetics in psychiatry: state of the art].
    Müller DJ; Brandl EJ; Degenhardt F; Domschke K; Grabe H; Gruber O; Hebebrand J; Maier W; Menke A; Riemenschneider M; Rietschel M; Rujescu D; Schulze TG; Tebartz van Elst L; Tüscher O; Deckert J;
    Nervenarzt; 2018 Mar; 89(3):290-299. PubMed ID: 29383410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of antipsychotic therapy: pivotal research issues and the prospects for clinical implementation.
    Lerer B; Segman RH
    Dialogues Clin Neurosci; 2006; 8(1):85-94. PubMed ID: 16640118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the pharmacogenetic prediction of antipsychotic response.
    Arranz MJ; Kerwin RW
    Toxicology; 2003 Oct; 192(1):33-5. PubMed ID: 14511901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP 2D6 polymorphism and antipsychotic therapy.
    Plesnicar BK; Dolzan V; Zalar B
    Psychiatr Danub; 2008 Sep; 20(3):369-71. PubMed ID: 18827765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment.
    Reynolds GP; Templeman LA; Zhang ZJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1021-8. PubMed ID: 15953671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics of antipsychotics: recent progress and methodological issues.
    Zhang JP; Malhotra AK
    Expert Opin Drug Metab Toxicol; 2013 Feb; 9(2):183-91. PubMed ID: 23199282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics and psychoactive drug therapy: ready for the patient?
    Steimer W
    Ther Drug Monit; 2010 Aug; 32(4):381-6. PubMed ID: 20526233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical applications of pharmacogenetics in psychiatry.
    Staddon S; Arranz MJ; Mancama D; Mata I; Kerwin RW
    Psychopharmacology (Berl); 2002 Jun; 162(1):18-23. PubMed ID: 12107612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomics and the future of pharmacotherapy in psychiatry.
    Malhotra AK; Lencz T; Correll CU; Kane JM
    Int Rev Psychiatry; 2007 Oct; 19(5):523-30. PubMed ID: 17896232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression to the truth: replication of association in pharmacogenetic studies.
    Ryan SG
    Pharmacogenomics; 2003 Mar; 4(2):201-7. PubMed ID: 12605554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commercial Pharmacogenetic Tests in Psychiatry: Do they Facilitate the Implementation of Pharmacogenetic Dosing Guidelines?
    Fan M; Bousman CA
    Pharmacopsychiatry; 2020 Jul; 53(4):174-178. PubMed ID: 30900236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of pharmacogenetics to psychotic disorders: the first consensus conference. The Consensus Group for Outcome Measures in Psychoses for Pharmacological Studies.
    Rietschel M; Kennedy JL; Macciardi F; Meltzer HY
    Schizophr Res; 1999 May; 37(2):191-6. PubMed ID: 10374654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.